Literatur
Pressekonferenz „AbbVie Clinical Development Programme“ anlässlich der EASL Jahrestagung 2014; London, April 2014 (Veranstalter: AbbVie)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Warpakowski, A. Orales, interferonfreies „3D“-Therapieregime. MMW - Fortschritte der Medizin 156 (Suppl 24), 64 (2014). https://doi.org/10.1007/s15006-014-3126-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-014-3126-3